drugset / Trial / NCT00786318
Ziprasidone vs Standard Therapy for Agitated Patients in the ED
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary objective is to determine if ziprasidone is superior to standard therapies in the emergency department treatment of the acutely agitated patient. The primary outcome will be the length of time taken until the patient is ready to be evaluated by the psychiatric service, or until a disposition is made.
Timeline
- Start
- 2008-09
- Primary completion
- 2011-07
- Completion
- 2011-07
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 5 mg | Intramuscular |
| Comparator | Lorazepam | Small molecule | 2 mg | Intramuscular |
| Subject | Ziprasidone | Small molecule | 20 mg | Intramuscular |